Axcelis Technologies Inc (ACLS)
| Market Cap | $2.79B+21.8% |
| Revenue (ttm) | $890.24M |
| Net Income | $104.56M |
| EPS | $3.36 |
| Shares Out | 30.88M |
| PE Ratio | 26.86 |
| Forward PE | 14.56 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 391,753 |
| Open | $96.16 |
| Previous Close | $99.94 |
| Day's Range | $89.06 - $96.57 |
| 52-Week Range | $73.60 - $193.78 |
| Beta | 1.89 |
| Analysts | Buy |
| Price Target | $132.00(+46.24%) |
| Earnings Date | Nov 5, 2026 |
About ACLS
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force. Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating ACLS in the last 3 months, one vote each. Issuer-paid research is not counted.
$ACLS stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ACLS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ACLS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ACLS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ACLS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ACLS from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from ACLS’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat and CFO change signal operational momentum; multiple bullish analyst pieces discussing growth outperformance; conference participation indicates business traction.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| TINY | ProShares - Nanotechnology ETF | 3.95% |
| WGRO | WisdomTree U.S. Growth & Momentum Fund | 1.79% |
| GBGR | Global Beta Rising Stars ETF | 1.71% |
| PSCT | Invesco S&P SmallCap Information Technology ETF | 1.57% |
| XSHQ | Invesco S&P SmallCap Quality ETF | 0.71% |
| CHIP | REX AI Chipmaking ETF | 0.56% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.56% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.46% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.45% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.44% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.41% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.41% |
Weight is the stock’s share of each fund’s holdings.
